Concepedia
Statistics
Publications
24
Citations
1.1K
H-Index
15
Active since
1992
Affiliations
Pfizer (United States)(Current)
Gifu University
Aichi Cancer Center
Pfizer (United Kingdom)
Osaka City University
Norimitsu Shirai is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacy.
Publications per year
1992–2023
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text
Pharmacy, Infectious Diseases, Pharmacology +15
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 159 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore et al. · EBioMedicine · 2018 · 150 citations · Full text
Life Sciences, Biochemistry, Pharmacology +17
Foreign gene expression by a baculovirus vector with an expanded host range
Hajime Mori, Hiroshi Nakazawa, Norimitsu Shirai et al. · Journal of General Virology · 1992 · 57 citations
Life Sciences, Entomology, Molecular Biology +14
Proliferative Activity of Canine Mast Cell Tumours Evaluated by Bromodeoxyuridine Incorporation and Ki-67 Expression
H. Sakai, Ayako Noda, Norimitsu Shirai et al. · Journal of Comparative Pathology · 2002 · 55 citations
Veterinary Medicine, Oncology, Veterinary Oncology +11
1–5 of 24